Both in Biotechnology
Acumen Pharmaceuticals vs Dyadic International
Over the past year ABOS returned −89.5% and DYAI returned −67.3%; their daily moves had a correlation of -0.02.
ABOS −89.5% DYAI −67.3%Growth of $1, one year, split-adjusted
| Metric | ABOS | DYAI |
|---|---|---|
| Price | $0.2138 | $0.3401 |
| Market cap | $15.5M | $13.6M |
| Today | −1.16% | −7.25% |
| 1 month | −89.8% | −25.5% |
| 6 months | −91.3% | −54.3% |
| Year to date | −89.9% | −63.8% |
| 1 year | −89.0% | −67.6% |
| Revenue growth (YoY) | — | −0.6% |
| Gross margin | — | −2.4% |
| Net margin | — | −221.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.6× |
| Net cash | $52.3M | -$1.9M |
| Dividend yield | — | — |
| Volatility (60d) | 492.8% | 70.4% |
| Short % of float | 7.6% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).